financetom
Business
financetom
/
Business
/
Merck Gets Keytruda Combination Approval for Cervical Cancer in Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck Gets Keytruda Combination Approval for Cervical Cancer in Canada
Jul 21, 2025 9:11 AM

11:40 AM EDT, 07/21/2025 (MT Newswires) -- Merck ( MRK ) said Monday that Health Canada has approved Keytruda in combination with chemoradiotherapy to treat adult patients with FIGO 2014 Stage III-IVA cervical cancer.

FIGO refers to International Federation of Gynecology and Obstetrics.

The drugmaker said the approval followed a statistically significant improvement in overall survival and progression-free survival in patients with Stage III-IVa in a late-stage trial.

Price: 79.19, Change: -0.77, Percent Change: -0.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved